Verona Pharma plc: Issue of Equity and Total Voting Rights

Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that it has issued 55,000 ordinary shares of 5 pence each (the “New Ordinary Shares”) following the vesting of restricted stock units held by a former employee.

Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM, with dealings expected to commence on July 10, 2020 (“Admission”).

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH